Hutch News

Hutch News

Stories tagged 'Frederick R Appelbaum'

Dr. Paul Neiman, founding member of Fred Hutch, dies at 78

Physician-scientist led the charge in prioritizing fundamental research, built bridges between lab and clinic

Oct. 12, 2017 | By Rachel Tompa / Fred Hutch News Service

Dr. Paul Neiman, a founding member of Fred Hutchinson Cancer Research Center and a transplant physician and cancer biologist, died Oct. 11 of complications from pancreatic cancer. He was 78. Neiman was also one of the founders and leaders of the Basic Sciences Division, one of the Hutch’s five scientific divisions, as well as the division that would later became the Human Biology Division. He served as director of Basic Sciences from 1983 to 1995. He retired from Fred Hutch in 2010.

View story >


Bringing a leukemia treatment back to life with precision medicine

New research writes latest chapter in one drug's story

June 27, 2017 | by Susan Keown / Fred Hutch News Service

The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 22, 2016

For fourth year in a row, Fred Hutch/SCCA transplant rates among best in the U.S.; immuntherapy symposium available on video for those who couldn't attend the event

View story >


‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science

Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies

Dec. 16, 2016 | By Susan Keown / Fred Hutch News Service

Lymphoma survivor Stephanie Florence said she wouldn't be alive if not for the science done at Fred Hutchinson Cancer Research Center. This week, she cut the ribbon at the grand opening of the Bezos Family Immunotherapy Clinic, which will make it possible for twice as many patients like Florence to receive treatment.

View story >


'Back to normal life'

Sorting stem cells before transplant helps lower the risk of graft-vs.-host disease, researcher reports

Dec. 5, 2016 | By Bill Briggs / Fred Hutch News Service

Patients in a clinical trial, including Dr. Curtis Mack, had lower rates of graft-vs.-host disease when researchers filtered stem cells before transplant, scientists reported Monday.

View story >


Physician-scientist Dr. Bruce Clurman named executive vice president and deputy director of Fred Hutch

Clurman will focus on team science, interdisciplinary collaboration in pursuit of new cures, said President and Director Dr. Gary Gilliland

Oct. 18, 2016 | By Rachel Tompa / Fred Hutch News Service

In his 25th year as a physician and researcher working at Fred Hutchinson Cancer Research Center, Dr. Bruce Clurman is getting ready to step into his newest role — executive vice president and deputy director of the Hutch.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.